158602-36-9 Usage
Uses
Used in Organic Synthesis:
1-Boc-3-(iodoethyl)azetidine is used as a synthetic intermediate for the preparation of various complex organic molecules. The Boc protecting group allows for selective reactions to occur at the iodoethyl moiety, while the iodine atom can be used for further functionalization or coupling reactions.
Used in Chemical Reactions:
1-Boc-3-(iodoethyl)azetidine is used as a reagent in various chemical reactions, such as cross-coupling reactions, where the iodine atom can be replaced by other metal or organic groups. This versatility makes it a valuable compound in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
1-Boc-3-(iodoethyl)azetidine is used as a building block for the synthesis of drug candidates. Its unique structure and reactivity enable the creation of novel compounds with potential therapeutic applications, such as new antibiotics, anticancer agents, or other targeted therapies.
Used in Research and Development:
1-Boc-3-(iodoethyl)azetidine is used as a research tool in academic and industrial laboratories. It serves as a model compound for studying reaction mechanisms, exploring new synthetic methodologies, and testing the potential of novel catalysts or reagents in the context of organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 158602-36-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,6,0 and 2 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 158602-36:
(8*1)+(7*5)+(6*8)+(5*6)+(4*0)+(3*2)+(2*3)+(1*6)=139
139 % 10 = 9
So 158602-36-9 is a valid CAS Registry Number.
158602-36-9Relevant academic research and scientific papers
Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets
-
, (2008/06/13)
Fibrinogen receptor antagonists of the formula: STR1 are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
